z-logo
open-access-imgOpen Access
Failure of Daptomycin Monotherapy for Endocarditis Caused by an Enterococcus faecium Strain with Vancomycin-Resistant and Vancomycin-Susceptible Subpopulations and Evidence of In Vivo Loss of the vanA Gene Cluster
Author(s) -
César A. Arias,
Harrys A. Torres,
Kavindra V. Singh,
Diana Panesso,
John E. Moore,
Audrey Wanger,
Barbara E. Murray
Publication year - 2007
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/522656
Subject(s) - daptomycin , vancomycin , medicine , enterococcus faecium , endocarditis , microbiology and biotechnology , enterococcus , gentamicin , ampicillin , antibiotics , bacteremia , antibacterial agent , in vivo , staphylococcus aureus , biology , bacteria , genetics
A patient with native valve endocarditis caused by a vancomycin "heteroresistant" strain of Enterococcus faecium experienced failure of daptomycin monotherapy without evidence of daptomycin resistance. The infecting organism exhibited in vivo emergence of a vancomycin-susceptible subpopulation lacking vanA. Treatment with a combination of high-dose daptomycin, gentamicin, and high-dose ampicillin cleared the infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom